Inventor · disambiguated record
V. Michael Holers
Also filed as: HOLERS V M · HOLERS V MICHAEL
21 granted patents·9 pending applications·105 citations·filing 2003–2024
94Inventor score
Files withUNIV COLORADO REGENTS11HOLERS V MICHAEL5MUSC FOUND FOR RES DEV3THURMAN JOSHUA M2ALEXION CAMBRIDGE CORP1
Top patents by PatentIndex Score
30 records- 0192US7759304B2Targeting complement factor H for treatment of diseasesUNIV COLORADO·Filed 2007·Granted Jul 20, 2010·26 cites·20 claims
- 0288US7964705B2Humaneered anti-factor B antibodyTALIGEN THERAPEUTICS INC·Filed 2008·Granted Jun 21, 2011·24 cites·4 claims
- 0387US8007804B2Complement receptor 2 targeted complement modulatorsMUSC FOUND FOR RES DEV·Filed 2003·Granted Aug 30, 2011·23 cites·12 claims
- 0486US9259488B2Anti-C3d antibody conjugates and methods of detecting complement activationUNIV COLORADO REGENTS·Filed 2015·Granted Feb 16, 2016·4 cites·20 claims
- 0584US8937046B2Modulating the alternative complement pathwayTHURMAN JOSHUA M·Filed 2009·Granted Jan 20, 2015·5 cites·6 claims
- 0682US9815890B2Antibodies to the C3d fragment of complement component 3HOLERS V MICHAEL·Filed 2011·Granted Nov 14, 2017·7 cites·18 claims
- 0781US11191851B2Anti-C3d antibody conjugates and methods of detecting complement activationMUSC FOUND FOR RES DEV·Filed 2019·Granted Dec 7, 2021·1 cites·9 claims
- 0876US8858945B2Three-dimensional structure of complement receptor type 2 and uses thereofUNIV COLORADO REGENTS·Filed 2013·Granted Oct 14, 2014·0 cites·13 claims
- 0975US8703140B2Inhibition of factor B, the alternative complement pathway and methods related theretoHOLERS V MICHAEL·Filed 2007·Granted Apr 22, 2014·2 cites·15 claims
- 1075US2025000955A1Map44 polypeptides and constructs based on natural antibodies and uses thereofUNIV COLORADO REGENTS·Filed 2024·Application pending·0 cites
- 1172US10233235B2Modulating the alternative complement pathwayUNIV COLORADO REGENTS·Filed 2014·Granted Mar 19, 2019·1 cites·41 claims
- 1272US8840868B2Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticlesTHURMAN JOSHUA M·Filed 2010·Granted Sep 23, 2014·4 cites·7 claims
- 1372US8569225B2Targeting complement factor H for treatment of diseasesGILKESON GARY·Filed 2010·Granted Oct 29, 2013·3 cites·25 claims
- 1471US9212212B2Targeting complement factor H for treatment of diseasesUNIV COLORADO REGENTS·Filed 2013·Granted Dec 15, 2015·1 cites·13 claims
- 1570US11407820B2Modulating the alternative complement pathwayUNIV COLORADO REGENTS·Filed 2018·Granted Aug 9, 2022·0 cites·20 claims
- 1670US10239937B2Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysisHOLERS V MICHAEL·Filed 2010·Granted Mar 26, 2019·1 cites·33 claims
- 1769US8540997B2Complement receptor 1 and 2 fusion proteinsTOMLINSON STEPHEN·Filed 2011·Granted Sep 24, 2013·1 cites·13 claims
- 1866US10278986B2Antibody-siRNA conjugates and uses thereforUNIV COLORADO REGENTS·Filed 2015·Granted May 7, 2019·1 cites·20 claims
- 1961US2021213110A1Map44 polypeptides and constructs based on natural antibodies and uses thereofUNIV COLORADO REGENTS·Filed 2020·Application pending·0 cites
- 2061US2021388080A1Targeting constructs based on natural antibodies and uses thereofUNIV COLORADO REGENTS·Filed 2021·Application pending·0 cites
- 2159US2014154307A1Inhibition of factor b, the alternative complement pathway and methods related theretoMUSC FOUND FOR RES DEV·Filed 2014·Application pending·0 cites
- 2259US2009324585A1Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritisUNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 2353USRE49339EAntibodies to the C3D fragment of complement component 3UNIV COLORADO REGENTS·Filed 2011·Granted Dec 20, 2022·0 cites·20 claims
- 2450US9650447B2Complement receptor 2 (CR2) targeting groupsKOVACS JAMES M·Filed 2011·Granted May 16, 2017·1 cites·28 claims
- 2550US2013078245A1ANTIBODIES TO THE C3d FRAGMENT OF COMPLEMENT COMPONENT 3HOLERS V MICHAEL·Filed 2012·Application pending·0 cites
- 2649US10413620B2Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imagingUNIV COLORADO REGENTS·Filed 2015·Granted Sep 17, 2019·0 cites·21 claims
- 2748US9096677B2Humaneered anti-factor B antibodyALEXION CAMBRIDGE CORP·Filed 2012·Granted Aug 4, 2015·0 cites·22 claims
- 2847US2007123466A1Method of treating recurrent miscarriagesUNIVERSUTY OF COLORADO·Filed 2004·Application pending·0 cites
- 2946US2011318337A1Humaneered anti-factor b antibodyEMLEN WOODRUFF·Filed 2011·Application pending·0 cites
- 3040US2012108492A1Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereofHOLERS V MICHAEL·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when V. Michael Holers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →